Literature DB >> 31087397

Extranodal extension in oral cancer: A role for the nodal microenvironment?

Alice E Pilborough1, Daniel W Lambert1, Syed A Khurram1.   

Abstract

Oral squamous cell carcinoma (OSCC) is a significant cause of morbidity and mortality worldwide and accounts for the majority of head and neck cancers. Metastasis of primary tumours, primarily to cervical lymph nodes in the neck, is associated with worsening prognosis. Furthermore, the prognosis of patients with extranodal extension of metastatic tumour from the lymph nodes into the neck tissues is particularly poor. The factors affecting this process are poorly understood, and detection is difficult pre-surgery. Mounting evidence shows that components of the tumour microenvironment including cancer-associated fibroblasts, vascular and lymphatic endothelial cells, the extracellular matrix and inflammatory immune cells, are important modulators of tumour behaviour in primary OSCC and other cancers. However, little is known about the lymph node microenvironment, its response to tumour presence and role in extranodal extension. In addition, there are many lymph node-specific cell types and structures, such as fibroblast reticular cells and high endothelial venules, making the lymph node microenvironment distinct from that found at primary tumour sites, and which contribute to the nodal response to tumour presence. This review details the current knowledge regarding the lymph node tumour microenvironment in OSCC and its role in lymph node metastasis and extranodal extension and relates this to features of the primary tumour. Understanding the role that the lymph node microenvironment plays in promoting tumour development and extranodal extension may aid the identification of novel biomarkers and alternative treatment strategies to improve the prognosis of patients with advanced OSCC.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  extracapsular spread; extranodal extension; lymph node metastasis; oral cancer; oral squamous cell carcinoma; tumour microenvironment

Year:  2019        PMID: 31087397     DOI: 10.1111/jop.12870

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  9 in total

1.  Predictors of Extracapsular Spread in T1/T2 Oral Squamous Cell Carcinoma: A retrospective study.

Authors:  Sapna Tandon; Rathindra Nath Bera; Akhilesh Kumar Singh; Madan Mishra
Journal:  J Oral Biol Craniofac Res       Date:  2022-05-27

2.  Histopathological Definitions of Extranodal Extension: A Systematic Review.

Authors:  Chadi Nimeh Abdel-Halim; Tine Rosenberg; Stine Rosenkilde Larsen; Poul Flemming Høilund-Carlsen; Jens Ahm Sørensen; Max Rohde; Christian Godballe
Journal:  Head Neck Pathol       Date:  2020-09-12

3.  Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.

Authors:  Yuri Noda; Mitsuaki Ishida; Yasuhiro Ueno; Takuo Fujisawa; Hiroshi Iwai; Koji Tsuta
Journal:  BMC Cancer       Date:  2022-04-13       Impact factor: 4.430

4.  Differential expression of podoplanin in metastatic lymph node is associated with extranodal extension in oropharyngeal cancer.

Authors:  Hye Ran Lee; Jin Roh; Ga Young Gu; Ju Ho Lee; Yoo Seob Shin; Jeon Yeob Jang; Chul-Ho Kim
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

5.  Prognostic Value of Neutrophil Percentage-to-Albumin Ratio in Patients with Oral Cavity Cancer.

Authors:  Chien-An Ko; Ku-Hao Fang; Ming-Shao Tsai; Yi-Chan Lee; Chia-Hsuan Lai; Cheng-Ming Hsu; Ethan I Huang; Geng-He Chang; Yao-Te Tsai
Journal:  Cancers (Basel)       Date:  2022-10-06       Impact factor: 6.575

6.  Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma.

Authors:  Shuo Liu; Zhen Qin; Yaqing Mao; Wenbo Zhang; Yujia Wang; Lingfei Jia; Xin Peng
Journal:  Oncoimmunology       Date:  2022-09-30       Impact factor: 7.723

Review 7.  Tumor microenvironment and immunotherapy of oral cancer.

Authors:  Chang Liu; Min Wang; Haiyang Zhang; Chunyan Li; Tianshou Zhang; Hong Liu; Song Zhu; Jie Chen
Journal:  Eur J Med Res       Date:  2022-10-08       Impact factor: 4.981

8.  Maintenance tegafur-plus-uracil after adjuvant concurrent chemoradiotherapy may improve outcome for resected oral cavity squamous cell carcinoma with extranodal extension.

Authors:  Pei-Wei Huang; Chien-Yu Lin; Li-Yu Lee; Chia-Hsun Hsieh; Cheng-Lung Hsu; Chi-Ting Liau; Kang-Hsing Fan; Shiang-Fu Huang; Chun-Ta Liao; Tung-Chieh Chang; Hung-Ming Wang
Journal:  Front Oncol       Date:  2022-09-28       Impact factor: 5.738

9.  Prognosis Value of Platelet Counts, Albumin and Neutrophil-Lymphocyte Ratio of Locoregional Recurrence in Patients with Operable Head and Neck Squamous Cell Carcinoma.

Authors:  Jing Ye; Bing Liao; Xiaohua Jiang; Zhihuai Dong; Sunhong Hu; Yuehui Liu; Mang Xiao
Journal:  Cancer Manag Res       Date:  2020-01-31       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.